| 논문분류 | 춘계학술대회 초록집 |
|---|---|
| 제목 | Renal outcome of heart failure patients with left ventricular assist device |
| 저자 | HOJIN JEON, Junseok Jeon, Darae Kim, Yang Hyun Cho, Jung Eun Lee, Jin-Oh Choi, Wooseong Huh, Yoon-Goo Kim, Hye Ryoun Jang |
| 출판정보 | 2021; 2021(1): |
| 키워드 | |
| 초록 | Objective: A total of 46 patients who were followed up for ≥ 1 year after receiving LVAD between 2012 and 2019 were included. Serial changes in renal function for up to 1 year after LVAD were analyzed depending on RRT or heart transplantation (HT). Methods: The median age was 64 years and 78% of patients were male. Fourteen patients (30%) received RRT before the LVAD operation and 11 patients (24%) received HT between 6 months and 1 year after LVAD. Renal function was significantly improved in the RRT group and RRT was discontinued in all patients before discharge. The estimated glomerular filtration rate (eGFR) at post-LVAD 6 months was similar in the control (non-RRT) and RRT groups (control 64.40 ± 28.75 vs. RRT 59.05 ± 32.44 mL/min/1.73 m2, p-value 0.60). Post-LVAD 1-year eGFR was also comparable in the non-HT and HT groups (non-HT 61.00 ± 30.94 vs. HT 66.86 ± 25.92 mL/min/1.73 m2, p-value 0.58). Results: LVAD was associated with significant improvement in renal function, even in HF patients with severe CRS. Our data suggest that severe CRS requiring RRT may not be a contraindication for LVAD in end-stage HF patients. Conclusions: Objective: Left ventricular assist device (LVAD) is the latest treatment option for severe heart failure (HF) patients. Although several previous studies investigated changes in renal function of HF patients with cardiorenal syndrome (CRS) after LVAD, post-LVAD renal outcome in severe CRS patients receiving renal replacement therapy (RRT) before LVAD is unclear. We analyzed renal outcome in HF patients with LVAD according to the use of RRT. Methods: A total of 46 patients who were followed up for ≥ 1 year after receiving LVAD between 2012 and 2019 were included. Serial changes in renal function for up to 1 year after LVAD were analyzed depending on RRT or heart transplantation (HT). Results: The median age was 64 years and 78% of patients were male. Fourteen patients (30%) received RRT before the LVAD operation and 11 patients (24%) received HT between 6 months and 1 year after LVAD. Renal function was significantly improved in the RRT group and RRT was discontinued in all patients before discharge. The estimated glomerular filtration rate (eGFR) at post-LVAD 6 months was similar in the control (non-RRT) and RRT groups (control 64.40 ± 28.75 vs. RRT 59.05 ± 32.44 mL/min/1.73 m2, p-value 0.60). Post-LVAD 1-year eGFR was also comparable in the non-HT and HT groups (non-HT 61.00 ± 30.94 vs. HT 66.86 ± 25.92 mL/min/1.73 m2, p-value 0.58). Conclusions: LVAD was associated with significant improvement in renal function, even in HF patients with severe CRS. Our data suggest that severe CRS requiring RRT may not be a contraindication for LVAD in end-stage HF patients. |
| 원문(PDF) | PDF 원문보기 |